Community-based Nurse-Guided Intervention for COVID-19 Recovery
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) for COVID-19 recovery?
The COVID-19 Care Companion Program in Punjab, India, showed that phone-supported recovery can effectively help COVID-19 patients manage symptoms at home, suggesting that community-based interventions can be beneficial. Additionally, storytelling interventions have been found to aid in the mental and emotional recovery of COVID-19 patients, indicating that relational support can play a role in recovery.12345
Is the Community-based Nurse-Guided Intervention for COVID-19 Recovery safe for humans?
How is the iCINGS FAM treatment for COVID-19 recovery different from other treatments?
The iCINGS FAM treatment is unique because it is a community-based intervention guided by nurses, focusing on integrating family support in the recovery process. This approach is different from traditional treatments as it emphasizes remote, nurse-led care and family involvement, which can be particularly beneficial for patients recovering at home or in community settings.35689
What is the purpose of this trial?
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.
Research Team
Gayenell S Magwood, PhD
Principal Investigator
University of South Carolina
Eligibility Criteria
This trial is for African American adults over 18 living in medically underserved areas of South Carolina, with a history of COVID-19 hospitalization and chronic conditions like diabetes, hypertension, or heart disease. They must be caring for someone with similar health issues within a close proximity but cannot be paid caregivers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of participants before randomization into intervention or control groups
Intervention
iCINGS FAM intervention with two planning sessions over 2 weeks followed by eight topic-guided sessions over 12 weeks
Attention Control
Monthly scripted phone calls focused on general health risks and health promotion
Follow-up
Participants are monitored for changes in health outcomes and behaviors at months 4 and 7
Treatment Details
Interventions
- Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
University of South Carolina
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator